ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -7.1% | 600 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $14 | +27.3% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $11 | +10.0% | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 600 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $10,000 | +25.0% | 600 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -46.7% | 600 | -25.0% | 0.00% | -100.0% |
| Q1 2022 | $15,000 | +114.3% | 800 | +166.7% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -12.5% | 300 | -62.5% | 0.00% | – |
| Q1 2021 | $8,000 | -27.3% | 800 | +300.0% | 0.00% | -100.0% |
| Q4 2020 | $11,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |